Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Dermatological Treatment|May 2, 2024
Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up studyNina Magnolo, Michael C Cameron, Mona Shahriari, et al.
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|October 17, 2022
Allergen Content and Protease Activity in Milk Feeds from Mothers of Preterm InfantsKathleen Luskin, Diba Mortazavi, Sherry Bai-Tong, et al.
Clinical and Experimental Immunology|October 8, 2022
Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficienciesRoger H Kobayashi, Jiří Litzman, Isaac Melamed, et al.
Dermatology and Therapy|September 23, 2025
Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?Eric L Simpson, Jonathan I Silverberg, Bob Geng, et al.
Cold Spring Harbor Molecular Case Studies|December 28, 2022
Rapid genome sequencing identifies novel variants in complement factor IKatherine M Rodriguez, Jordan Vaught, Michelle Dilley, et al.
Dermatology and Therapy|February 12, 2026
Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 StudiesAndrew Blauvelt, Leon Kircik, Eric L Simpson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2021
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory StudiesBob Geng, Claus Bachert, William W Busse, et al.
Scientific Reports|April 20, 2022
The impact of maternal asthma on the preterm infants' gut metabolome and microbiome (MAP study)Shiyu S Bai-Tong, Megan S Thoemmes, Kelly C Weldon, et al.
Journal of Clinical Immunology|March 27, 2025
Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement TherapyMorna J Dorsey, Manish J Butte, Jay A Lieberman, et al.
Pediatric Pulmonology|July 17, 2026
Current Practices and Variations Among Pediatric Severe Asthma Programs in the United States-The North American Severe Pediatric Asthma ConsortiumKristina Gaietto, Nadia Krupp, Avani V Shah, et al.
Pageof 6